ABOUT HAMMOND HANLON CAMP LLC

Hammond Hanlon Camp LLC (“H2C”) is an independent strategic advisory and investment banking firm committed to providing superior advice as a trusted advisor to healthcare organizations throughout the United States. H2C’s professionals have a long track record of success in healthcare mergers & acquisitions, capital markets, real estate and restructuring transactions, acting as lead advisors on hundreds of transactions representing billions of dollars in value. Hammond Hanlon Camp LLC offers securities through its wholly-owned subsidiary H2C Securities Inc., member FINRA/SIPC. For more information, go to h2c.com

 

MEDIA CONTACT

Dara Litwin
Hammond Hanlon Camp LLC
212.257.4527
dlitwin@h2c.com

NEW YORK

623 Fifth Avenue
29th Floor
New York, NY 10022
212.257.4500

 

ATLANTA

3333 Piedmont Road
Suite 700
Atlanta, GA 30305
404.937.1350

 

SAN DIEGO

11682 El Camino Real
Suite 320
San Diego, CA 92130
858.242.4800

CHICAGO

311 South Wacker Drive
Suite 5425
Chicago, IL 60606
312.508.4200

 

Hammond Hanlon Camp LLC ("H2C") Advises on the Sale of the Southern Maryland Hospital Center in Clinton, Maryland to MedStar Health
posted on February 11, 2013

 

Southern Maryland Hospital Center has completed the sale of its for-profit 262-bed acute care facility in Clinton, Maryland and related entities to MedStar Health, a leading not-for-profit healthcare system in Washington, D.C. and Maryland.

 

NEW YORK – Hammond Hanlon Camp LLC (“H2C”), a healthcare-focused investment banking firm, served as exclusive financial advisor to 

southern Maryland Hospital Center, leading the sales process to conclusion.  H2C highlighted to bidders Southern Maryland Hospital Center’s long history as an essential acute care provider on the Southern Maryland Peninsula and the hospital’s strong potential for organic growth.  Through a carefully managed sales process, H2C was able to obtain several highly competitive bids with fully negotiated asset purchase agreements prior to final selection of MedStar Health as a partner. The process focused on finding bidders that combined both leading healthcare delivery organizations with well-known academic medical centers.  As a result of H2C’s experience in sell side transactions, H2C maximized the purchase price, and secured significant future capital expenditure investments to grow the hospital’s services.  H2C completed the process from onset to closing within nine months.

 

“H2C did an excellent job in the sale of Southern Maryland Hospital Center.  The H2C team performed superbly, created a robust auction for Dr. Chiaramonte’s life’s work, and ensured the hospital’s continued importance in the community for generations to come,” said Michael Chiaramonte, CEO of MedStar Southern Maryland Hospital Center. Venable LLP served as attorney for Southern Maryland for the transaction, and advised on tax, regulatory and real estate related issues.  The accounting and management consulting firm SC&H Group, LLC provided accounting and certain due diligence services.